유전자 편집 완벽 가이드.
메뉴
배우기 뉴스 아틀라스에 질문하기
둘러보기 기술들 질환 치료법들 임상시험 기업 과학자들 유전자 연구 기관
의학을 넘어서 농업 윤리 투자 세계 지도
배우기 & 도구 여기서 시작하세요 용어집 A–Z 기술 비교 타임라인 목록 & 순위 AI 에이전트 ★ 저장됨 API
소개 소개 방법론 데이터 출처 편집 방침 문의 면책 조항

🧭 안내 보기
유전학이 처음이신가요? 둘러보시는 동안 모든 용어를 쉬운 말로 설명해 드립니다. 도움말이 내장된 동일한 페이지입니다.

⚡ 전문가 견해
생물학은 이미 알고 계시죠. 내용만 — 깔끔하고 간결하게, 추가 설명 없이. 기본 보기입니다.

인터페이스 언어
라이트 모드

Intermediate

Lipid nanoparticles

Tiny fat bubbles that carry genetic cargo into cells — the delivery technology that made in vivo CRISPR possible.

짧은 답변

A lipid nanoparticle is a microscopic bubble of fat with the genetic cargo tucked inside. Injected into the blood, it naturally ends up in the liver, where cells absorb it and release the contents. It is the same delivery technology used in mRNA COVID-19 vaccines, and it is what made editing a gene inside a living person practical.

Lipid nanoparticles comprise an ionisable lipid, a helper phospholipid, cholesterol and a PEG-lipid. After intravenous administration they acquire an ApoE corona and are taken up by hepatocytes via the LDL receptor, then escape the endosome as the ionisable lipid protonates. Cargo — typically Cas9 mRNA plus guide RNA — is expressed transiently, which limits editor exposure and off-target opportunity. Redosing is possible, unlike with AAV.

Advantages that matter clinically

Where the analogy breaks downThe great limitation is tropism. Left to themselves, lipid nanoparticles go to the liver. Redirecting them to other tissues is one of the most actively pursued problems in the field, and solving it would unlock more diseases than any advance in editing chemistry.

Sources

Connected in the Atlas

Every entry on this site is linked to the others it relates to. These connections are part of the record, not a search result.

Technologies

Base Editing